Xavier Warling

1.6k total citations
17 papers, 421 citations indexed

About

Xavier Warling is a scholar working on Nephrology, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine. According to data from OpenAlex, Xavier Warling has authored 17 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Xavier Warling's work include Parathyroid Disorders and Treatments (5 papers), Dialysis and Renal Disease Management (4 papers) and Vitamin D Research Studies (3 papers). Xavier Warling is often cited by papers focused on Parathyroid Disorders and Treatments (5 papers), Dialysis and Renal Disease Management (4 papers) and Vitamin D Research Studies (3 papers). Xavier Warling collaborates with scholars based in Belgium, France and United States. Xavier Warling's co-authors include Jean-Marie Krzesinski, Pierre Delanaye, Étienne Cavalier, Martial Moonen, Hans Pottel, Robert Fagard, Maria Van den Enden, Marc Leeman, Olivier Bruyère and Laurent Weekers and has published in prestigious journals such as Scientific Reports, Clinica Chimica Acta and Nephrology Dialysis Transplantation.

In The Last Decade

Xavier Warling

16 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xavier Warling Belgium 8 175 115 109 88 48 17 421
Bhupesh Panwar United States 12 189 1.1× 70 0.6× 57 0.5× 106 1.2× 51 1.1× 14 495
Cédric Gauci France 9 449 2.6× 68 0.6× 93 0.9× 128 1.5× 52 1.1× 10 691
Young Shin Shin South Korea 10 297 1.7× 108 0.9× 137 1.3× 265 3.0× 71 1.5× 18 628
Ivone B. Oliveira Brazil 13 174 1.0× 105 0.9× 100 0.9× 40 0.5× 88 1.8× 26 472
Kanji Shishido Japan 12 216 1.2× 66 0.6× 43 0.4× 40 0.5× 19 0.4× 26 360
John Kyriazis Greece 15 283 1.6× 72 0.6× 133 1.2× 24 0.3× 54 1.1× 22 600
Anna Jovanovich United States 13 257 1.5× 85 0.7× 59 0.5× 89 1.0× 33 0.7× 28 502
Paola Pecchini Italy 7 285 1.6× 68 0.6× 61 0.6× 277 3.1× 91 1.9× 12 499
Paweł Stróżecki Poland 12 169 1.0× 44 0.4× 162 1.5× 49 0.6× 18 0.4× 40 370
Sylva Skálová Czechia 13 138 0.8× 57 0.5× 24 0.2× 76 0.9× 103 2.1× 42 427

Countries citing papers authored by Xavier Warling

Since Specialization
Citations

This map shows the geographic impact of Xavier Warling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Warling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Warling more than expected).

Fields of papers citing papers by Xavier Warling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Warling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Warling. The network helps show where Xavier Warling may publish in the future.

Co-authorship network of co-authors of Xavier Warling

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Warling. A scholar is included among the top collaborators of Xavier Warling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Warling. Xavier Warling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Warling, Xavier, François Jouret, Antoine Lanot, et al.. (2025). Combination of Clinical Frailty Score and Myostatin Concentrations as Mortality Predictor in Hemodialysis Patients. Journal of Renal Nutrition. 35(5). 636–645.
2.
Delanaye, Pierre, Antoine Lanot, Antoine Bouquegneau, et al.. (2022). Monitoring 25-OH and 1,25-OH vitamin D levels in hemodialysis patients after starting therapy: Does it make sense?. Clinica Chimica Acta. 539. 50–54. 2 indexed citations
3.
Cavalier, Étienne, et al.. (2020). The percentage of non-oxidized PTH concentration remains stable over a period of 1 year in hemodialyzed patients. Clinica Chimica Acta. 506. 107–109. 3 indexed citations
4.
Delanaye, Pierre, Stanislas Bataille, Fanny Buckinx, et al.. (2019). Myostatin and Insulin-Like Growth Factor 1 Are Biomarkers of Muscle Strength, Muscle Mass, and Mortality in Patients on Hemodialysis. Journal of Renal Nutrition. 29(6). 511–520. 44 indexed citations
5.
Delanaye, Pierre, Xavier Warling, Martial Moonen, et al.. (2017). Variations of parathyroid hormone and bone biomarkers are concordant only after a long term follow-up in hemodialyzed patients. Scientific Reports. 7(1). 12623–12623. 4 indexed citations
6.
Delanaye, Pierre, Jean-Marie Krzesinski, Xavier Warling, et al.. (2014). Clinical and Biological Determinants of Sclerostin Plasma Concentration in Hemodialysis Patients. Nephron Clinical Practice. 128(1-2). 127–134. 54 indexed citations
7.
Moerman, Filip, Marjan Van Esbroeck, Éric Firre, et al.. (2014). A nephrotic syndrome of tropical origin: case report and short review of the aetiology. Acta Clinica Belgica. 69(5). 379–381. 4 indexed citations
8.
Delanaye, Pierre, Jean-Marie Krzesinski, Xavier Warling, et al.. (2014). Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. BMC Nephrology. 15(1). 145–145. 100 indexed citations
9.
Delanaye, Pierre, Étienne Cavalier, Olivier Moranne, et al.. (2013). Clinical and biological variables associated with mortality in hemodialysis patients. Open Repository and Bibliography (University of Liège). 2 indexed citations
10.
Delanaye, Pierre, Laurent Weekers, Xavier Warling, et al.. (2013). Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study. Nephrology Dialysis Transplantation. 28(7). 1779–1786. 61 indexed citations
11.
Krzesinski, Jean-Marie, et al.. (2011). Intérêt des interventions psychologiques en dialyse : étude exploratoire. Néphrologie & Thérapeutique. 7(4). 211–218. 7 indexed citations
12.
Moonen, Martial, Vincent Fraipont, Luc Radermacher, et al.. (2010). L’insuffisance rénale aiguë : du concept à la pratique. Néphrologie & Thérapeutique. 7(3). 172–177. 7 indexed citations
13.
Bovy, Christophe, A. Gothot, Pierre Delanaye, et al.. (2007). Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity. Nephrology Dialysis Transplantation. 22(4). 1156–1162. 37 indexed citations
14.
Fagard, Robert, Maria Van den Enden, Marc Leeman, & Xavier Warling. (2002). Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium. Journal of Hypertension. 20(7). 1297–1302. 91 indexed citations
15.
Krzesinski, Jean-Marie, Xavier Warling, Anne Goffard, & Georges Rorive. (1989). [Does dopamine play a role in renal anomaly in sodium excretion, a marker for hereditary predisposition to arterial hypertension?].. PubMed. 82(7). 1245–8. 3 indexed citations
16.
Warling, Xavier, P. Carlier, Jean-Marie Krzesinski, & Georges Rorive. (1988). La mesure ambulatoire de la pression artérielle permet d'améliorer la définition de l'hypertension artérielle. Archives Des Maladies Du Coeur Et Des Vaisseaux. 1 indexed citations
17.
Warling, Xavier, et al.. (1988). [Does ambulatory blood pressure measurement allow a better definition of arterial hypertension?].. PubMed. 81 Spec No. 225–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bhupesh Panwar Breakdown of academic impact, for papers by Cédric Gauci Breakdown of academic impact, for papers by Young Shin Shin Breakdown of academic impact, for papers by Ivone B. Oliveira Breakdown of academic impact, for papers by Kanji Shishido Breakdown of academic impact, for papers by John Kyriazis Breakdown of academic impact, for papers by Anna Jovanovich Breakdown of academic impact, for papers by Paola Pecchini Breakdown of academic impact, for papers by Paweł Stróżecki Breakdown of academic impact, for papers by Sylva Skálová
Rankless by CCL
2026